| Patents for C07D - Heterocyclic compounds (10,420) |
|---|
| 06/10/2004 | US20040110740 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-(hydroxymethyl)-3,3-dimethyl-7-oxo-, -1-(benzoyloxy)-alkyl ester, 4,4-dioxide derivative or solvate; can be mixed with beta-lactam antibiotic |
| 06/09/2004 | EP1425282A2 Process for the preparation of diketopyrrolopyrroles |
| 06/09/2004 | EP1425068A1 Systemical administration of some oxazolidinones, e.g. linezolid, for the treatment of ocular infections |
| 06/09/2004 | EP1180102B1 Mutual prodrugs of amlodipine and atorvastatin |
| 06/09/2004 | EP1098897B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1152880C Process for preparation of oxymorphone, oxycodone and derivatives |
| 06/09/2004 | CN1152871C Hydroxylamine derivative useful for enhancing molecular chaperon prodn. and the prep. thereof |
| 06/09/2004 | CN1152681C 8a-azalides as veterinary antimicrobial agents for animals |
| 06/08/2004 | US6747158 Anticoagulants |
| 06/08/2004 | US6747054 EP4 receptor selective agonists in the treatment of osteoporosis |
| 06/08/2004 | US6747024 Inhibiting calpain and/or reactive oxygen species in warm-blooded animals |
| 06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
| 06/03/2004 | WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 06/03/2004 | WO2004046103A2 Arylpyridine compounds |
| 06/03/2004 | WO2004046102A2 Novel graphite nanocatalysts |
| 06/03/2004 | WO2004046100A2 Release of the self-quenching of fluorescence near silver metallic surfaces |
| 06/03/2004 | WO2003032995A8 Rosuvastatin in pre demented states |
| 06/03/2004 | US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/02/2004 | EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 06/02/2004 | EP1114032B1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1500784A New process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts ofranelic acid and thei |
| 06/02/2004 | CN1500782A Process for the diastereoselective synthesis of nucleoside analogues |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 05/27/2004 | WO2004043958A1 Fused heterocyclic compounds |
| 05/27/2004 | WO2004043924A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/27/2004 | WO2004043913A2 Hetero-substituted benzimidazole compounds and antiviral uses thereof |
| 05/27/2004 | US20040102510 Cancer; the compounds interact with the amino acids in the catalytic region of PKs and bind in the general space normally occupied by the adenine ring of ATP |
| 05/27/2004 | CA2505372A1 Fused heterocyclic compounds |
| 05/27/2004 | CA2504766A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/26/2004 | EP1422217A2 Aminocyclohexyl ether compounds and uses thereof |
| 05/26/2004 | EP1421105A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 05/26/2004 | EP1421083A1 Novel imidazopyridine compounds with therapeutic effect |
| 05/26/2004 | EP1117652B1 Tan-1057 derivatives |
| 05/26/2004 | EP1015433B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 05/26/2004 | CN1151146C Process for diastereoselective synthesis of nucleoside analogues |
| 05/26/2004 | CN1151140C Glucokinase activators |
| 05/21/2004 | WO2004041817A1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 05/21/2004 | WO2004041800A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041777A2 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/21/2004 | WO2004009541A3 Antisense modulation of endothelial lipase expression |
| 05/21/2004 | CA2502733A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | CA2502178A1 Heteroarylpiperidine modulators of chemokine receptor activity |
| 05/20/2004 | US20040097471 For therapy and prophylaxis of influenza infection |
| 05/19/2004 | EP1419776A2 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/19/2004 | EP1419152A1 Hiv inhibiting pyrimidines derivatives |
| 05/19/2004 | EP1419151A1 Chrystals including a malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1021416B1 Method for producing substituted pyrazoles |
| 05/19/2004 | EP0984965B1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 05/19/2004 | EP0781136B1 Compounds and methods for the treatment of cancer |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150178C Sidechain-bearing taxanes |
| 05/19/2004 | CN1149990C Cyclooxygenase-2 inhibitor for treatment and prevention of tumors, tumor-related disorders and cachexia |
| 05/18/2004 | US6737437 EP4 receptor selective agonists in the treatment of osteoporosis |
| 05/13/2004 | WO2004039774A2 Mitotic kinesin inhibitors |
| 05/13/2004 | US20040092550 Anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092502 Central nervous system disorders; dietetics; psychological disorders; sleep disorders; sexual disorders |
| 05/13/2004 | CA2485343A1 Mitotic kinesin inhibitors |
| 05/12/2004 | EP1417180A1 Preparation of aminopyrimidine compounds |
| 05/12/2004 | EP1311485A4 Processes for preparing cilostazol |
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
| 05/12/2004 | CN1495177A C-10 position paclitaxane derivative and its medicine composition |
| 05/12/2004 | CN1495174A Preparation method of isoxazolylalkyldione compound |
| 05/12/2004 | CN1495169A Pyridine-3-carboxylic acid derivative |
| 05/12/2004 | CN1495162A Preparation of thiol carbamate and thiocyanic ester compound |
| 05/12/2004 | CN1495158A Intermediate for preparing isoxazolinyl-3-acylbenzene and process for preparing said intermediate |
| 05/12/2004 | CN1149210C Thrombin inhibitors |
| 05/12/2004 | CN1149200C 2-[(dihydro)pyrazole-3'-oxymethoylene]aniline amide and its preparation and use |
| 05/12/2004 | CN1149192C Process for preparing protected 4-aminomethyl-pyrrolidin-3-one |
| 05/11/2004 | US6734184 Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP) |
| 05/11/2004 | CA2225960C Pharmaceutical compositions |
| 05/11/2004 | CA2184411C Process for preparing polymorphs b and c of 1-[2,4-dichloro-.beta.-[(7-chlorobenzo[b]thien-3-yl)methoxy]phenethyl]imidazole mononitrate |
| 05/06/2004 | WO2004037783A2 Treatment of cognitive impairment using a selective dopamine d1 receptor agonist |
| 05/06/2004 | WO2003106416A3 Chemical process |
| 05/06/2004 | WO2003092580A3 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087547 Orally administered antitumor agents |
| 05/06/2004 | EP1415992A1 Diamine derivatives |
| 05/06/2004 | EP1415982A1 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414796A1 Crystalline forms vi and vii of atorvastatin calcium |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | CA2501781A1 Treatment of cognitive impairment using a selective dopamine d1 receptor agonist |
| 05/05/2004 | CN1493562A Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method |
| 05/05/2004 | CN1148350C Novel VLA-4 inhibitor: oMePUPA-V |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 04/29/2004 | WO2004035565A1 Method for the synthesis of a benzimidazole compound |
| 04/28/2004 | EP1413331A2 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) for vascular indications |
| 04/28/2004 | EP1412341A1 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram |
| 04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |